NCT06415279View on ClinicalTrials.gov

A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

February 18, 2025

Study Completion Date

February 18, 2025

Conditions

Acne Vulgaris

Interventions

DRUG

Winlevi (clascoterone) 1% cream

Twice daily (BID) dosing

Trial Locations (1)

27262

Dermatology Consulting Services, PLLC, High Point

All Listed Sponsors

lead

Sun Pharmaceutical Industries Limited

INDUSTRY

NCT06415279 - A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients | Biotech Hunter | Biotech Hunter